Julia James, DPhil, MGHS

Julia James, DPhil, MGHS, holds a doctorate in Clinical Medicine from Oxford University, which she attended as a Rhodes Scholar.  Her interest in studying HIV/AIDS goes back to her undergraduate years, when James focused on HIV/AIDS and studied the difference in molecular flexibility of protease inhibitor drugs.  She applied for the Rhodes scholarship to engage in collaborative research at Oxford involving long-term nonprogressors with HIV infection. James was intrigued by how some people exposed to HIV remained healthy in spite of the devastating effects of the virus in most people. She has completed basic scientific research on HIV ranging from computational research on the HIV-1 protease to basic immunology and microbiology to inform efforts to create an effective HIV-1 vaccine.  Dr. James’s thesis explored T cell receptor specificity and their potential to recognize emerging HIV-1 viral variants.  Her review of work in the area of Community Based Participatory Research ignited her interest in comparing methods of engaging the local community in HIV research.  Dr. James’s major areas of interest for her traineeship include the epidemiology of drug resistance to pre-exposure and post-exposure prophylaxis, immunology and HIV risk behavior, and implementation strategies for bridging scientific-community divides.  She completed a Master of Global Health Sciences degree at UCSF during her first year of TAPS training.  [Completes training June 30, 2015]

Last modified: September 13, 2013